Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Quentin30


T.ONC

Partnerships...

"With its impressive clinical data coupled with its unique and novel...

May 3, 2023

T.ONC

RE:Let’s keep the information as real as we can…why not

The current pps has EVERYTHING to do with the buyout price...  Are you...

April 23, 2023

T.ONC

RE:Forever bullish on the science...

There is almost no doubt in my mind that ONCY will postpone final data...

April 23, 2023

T.ONC

RE:RE:RE:RE:RE:RE:ONC/Y and the FDA

Agreed. The trials are so small as to limit any definite conclusions... are...

April 6, 2023

T.ONC

RE:RE:RE:RE:RE:RE:ONC/Y and the FDA

HI WestCoast, This may be ONCY's achilles heel actually... Pela is to be...

April 5, 2023

T.ONC

RE:RE:RE:RE:ONC/Y and the FDA

I would add to this vebture009. My work involves dealing with the FDA, and...

April 5, 2023

T.ONC

RE:Liability

I doubt it... although his constant references to bank robberies seems apt......

April 4, 2023

T.ONC

Valuation

Markets Up... ONCY down. Matt speaks, ONCY down Matt announces he will be...

March 29, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.

Why do you think Matt would state in his most recent podcast. that the mBC...

March 25, 2023

T.ONC

RE:Average cost to bring drug candidate to market = US$2.3 Bln

 More pump Noteable... "prime" the innate/adaptive immune...

March 15, 2023

T.ONC

RE:RE:Watched the Coffey interview

Oh dear, Matt really needs a new anecdote. I'm a movie guy... really Matt...

March 8, 2023

T.ONC

Not statistically significant

It's worth remembering that the Bracelet-1 trial is not powered to...

March 8, 2023

T.ONC

Well the market clearly loved the call... look at the stock

oh dear, down again...

March 3, 2023

T.ONC

RE:RE:Pfizer 90 day period expired

They did have a deal 4-5 years ago... they're called Adlai Nortye. And...

March 3, 2023

T.ONC

Pfizer 90 day period expired

Hmmm... so that period has expired. Pfizer has seen the data evolve... no...

March 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The Business of Biotech interview...

Nothing like rational debate is there Azzak34. Wow. Do you throw a hissy fit...

February 15, 2023

T.ONC

RE:Hard to find, under the threaded view…strong volume & price

Given that Matt has just presented, does this mean the multi-billion buyout...

February 13, 2023

T.ONC

RE:RE:Will keep my comments on ONC, ONCY.

That's a pretty dumb idea... that's like never speaking to anyone who...

February 9, 2023

T.ONC

RE:RE:RE:No-one has access to ONCY's manufacturing process

hmmm, I don't think it's 'evident'... why do you get so sh...

February 8, 2023

T.ONC

RE:RE:Good discussion

Well first Noteable, ONCY needs to demonstrate the CPI + Pela + Pax is...

February 7, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next